Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion type Assertion NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_head.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion evidence source_evidence_literature NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion SIO_000772 22718504 NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion wasDerivedFrom befree-20140225 NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion wasGeneratedBy ECO_0000203 NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.